Although our study was not designed to analyze NT or ME expression patterns in acute leukemia molecular subgroups, we also found significantly higher hENT1 levels in AML-MLL+ and lower DCK and cN-II levels in AML cases and T-ALL samples. This evidence concerns the gene SLC29A1 and acute myeloid leukemia.